The road to health, from Fuzhou, Fujian, received the notice of the China Securities Regulatory Commission's filing for listing in Hong Kong, issuing no more than approximately 109 million shares.

瑞恩資本RyanbenCapital · Jun 26 13:21

根据2023年3月31日生效的境内企业境外上市备案新规，企业选择香港H股上市，原大小路条已成为历史。企业境外上市可直接递交招股书，而大路条将被“备案通知书”代替。

2024年6月24日，中国证监会国际合作司发布关于HealthyWay Inc.（健康之路股份有限公司）境外发行上市备案通知书(国合函〔2024〕1314号)。

备案通知书具体如下：

HealthyWay Inc.（健康之路股份有限公司）：

你公司通过境内运营实体浙江健康之路科技集团有限公司提交的境外发行上市备案材料收悉。根据《中华人民共和国证券法》《境内企业境外发行证券和上市管理试行办法》等规定，我会对备案事项通知如下：

一、你公司拟发行不超过108,956,500股境外上市普通股并在香港联合交易所上市。

二、自本备案通知书出具之日起至本次境外发行上市结束前，你公司如发生重大事项，应根据境内企业境外发行上市有关规定，通过中国证监会备案管理信息系统报告。

三、你公司完成境外发行上市后15个工作日内，应通过中国证监会备案管理信息系统报告发行上市情况。你公司应当按承诺严格落实国家发展改革委、商务部、工业和信息化部等部门提出的整改要求，并在境外发行上市过程中严格遵守境内外有关法律、法规和规则。

四、你公司自本备案通知书出具之日起12个月内未完成境外发行上市，拟继续推进的，应当更新备案材料。

本备案通知书仅对企业境外发行上市备案信息予以确认，不表明中国证监会对该企业证券的投资价值或者投资者的收益作出实质性判断或者保证，也不表明中国证监会对企业备案材料的真实性、准确性、完整性作出保证或者认定。

中国证监会国际合作司

2024年6月24日

根据港交所上市规则，企业需在聆讯审批日期至少4个营业日之前需提交“备案通知书”，意味健康之路已取得进行香港上市聆讯的前置要求，或很快在港交所进行上市聆讯。

健康之路，最新于2023年12月29日在港交所递交招股书，其上市主要中介团队包括：建银国际为其独家保荐人；岭峰资本为其财务顾问；毕马威为其审计师；竞天公诚、普衡分别为其公司中国律师、公司香港及美国律师；通商、汉坤分别为其券商中国律师、券商香港律师；弗若斯特沙利文为其行业顾问。

健康之路，来自福建福州，作为中国健康及保健行业的服务平台，根据弗若斯特沙利文的资料，按截至2022年底平台注册个人用户数目计，公司目前经营着中国最大的数字健康医疗服务平台之一。截至2023年6月30日，在公司平台注册的个人用户达1.786亿名，注册医生达84.52万名，连接医院11,601家(其中三甲医院1,471家)。

健康之路招股书链接：

https://www1.hkexnews.hk/app/sehk/2023/106103/documents/sehk23122901798.pdf

According to the new overseas listing and filing regulations for domestic companies that came into effect on March 31, 2023, companies chose to list H-shares in Hong Kong. The original path of big and small is a thing of the past. Companies listed overseas can directly submit a prospectus, and the roadmap will be replaced by a “filing notice”.

On June 24, 2024, the International Cooperation Department of the China Securities Regulatory Commission issued a filing notice on the overseas issuance and listing of HealthyWay Inc. (Health Road Co., Ltd.) (Health Road Co., Ltd.) (Letter of State Cooperation (2024) No. 1314).

The details of the filing notice are as follows:

HealthyWay Inc. (HealthyWay Co., Ltd.):

Your company has received the overseas issuance and listing filing materials submitted by Zhejiang Health Road Technology Group Co., Ltd., a domestic operating entity. According to the “Securities Law of the People's Republic of China”, “Trial Measures on the Administration of Overseas Issuance and Listing of Domestic Enterprises”, etc., I will notify the filing matters as follows:

1. Your company intends to issue no more than 108,956,500 overseas listed common shares and list them on the Hong Kong Stock Exchange.

2. From the date this filing notice is issued until the end of this overseas issuance and listing, if important matters occur in your company, it shall be reported through the China Securities Regulatory Commission's filing management information system in accordance with the relevant regulations on overseas issuance and listing of domestic enterprises.

3. Within 15 working days after completing the overseas issuance and listing, your company shall report the issuance and listing status through the China Securities Regulatory Commission's Filing Management Information System. Your company should strictly implement the rectification requirements put forward by the National Development and Reform Commission, the Ministry of Commerce, the Ministry of Industry and Information Technology and other departments as promised, and strictly abide by relevant domestic and foreign laws, regulations, and rules in the overseas distribution and listing process.

4. If your company has not completed overseas distribution and listing within 12 months from the date of issuance of this filing notice and plans to proceed further, the filing materials should be updated.

This filing notice only confirms the company's overseas issuance and listing registration information. It does not indicate that the China Securities Regulatory Commission has made a substantive judgment or guarantee on the investment value of the enterprise's securities or investors' returns, nor does it indicate that the China Securities Regulatory Commission guarantees or determines the authenticity, accuracy, or completeness of the enterprise's filing materials.

China Securities Regulatory Commission International Cooperation Department

June 24, 2024

According to the Hong Kong Stock Exchange listing rules, companies are required to submit a “Notice of Filing” at least 4 business days before the date of approval of the hearing, which means that Health Path has obtained the preliminary requirements to conduct a Hong Kong listing hearing, or that the listing hearing will be held on the Hong Kong Stock Exchange soon.

Health Path recently submitted a prospectus on the Hong Kong Stock Exchange on December 29, 2023. Its main intermediary teams include: CCB International as its sole sponsor; Lingfeng Capital as its financial advisor; KPMG as its auditor; Jingtian Gongcheng and Pu Heng are its Chinese lawyers and Hong Kong and US lawyers respectively; Commerce and Han Kun are its Chinese lawyers and Hong Kong lawyers; and Frost Sullivan as its industry advisor.

Health Path, from Fuzhou, Fujian, is a service platform for the Chinese health and healthcare industry. According to Frost & Sullivan's data, based on the number of registered individual users of the platform as of the end of 2022, the company currently operates one of the largest digital healthcare service platforms in China. As of June 30, 2023, the number of registered individual users on the company's platform reached 178.6 million, the number of registered doctors reached 845,500, and connected to 11,601 hospitals (including 1,471 of the top three hospitals).

Link to the Health Path prospectus:

https://www1.hkexnews.hk/app/sehk/2023/106103/documents/sehk23122901798.pdf

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

健康之路，来自福建福州，赴香港上市获证监会备案通知书，发行不超过约1.09亿股

The road to health, from Fuzhou, Fujian, received the notice of the China Securities Regulatory Commission's filing for listing in Hong Kong, issuing no more than approximately 109 million shares.

Risk Disclaimer

Statement